<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00380809</url>
  </required_header>
  <id_info>
    <org_study_id>SK 106</org_study_id>
    <nct_id>NCT00380809</nct_id>
  </id_info>
  <brief_title>Rotational Atherectomy Prior to Taxus Stent</brief_title>
  <official_title>Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease. A Multicenter, Prospective, Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH</source>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to evaluate the long term effects of the polymer-based
      slow-release paclitaxel-eluting stent (TAXUS; Boston Scientific), with or without prior
      rotablation, in an angiographically well defined group of patients with complex calcified
      coronary lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Calcification is an essential part of all atherosclerotic plaques. Its extent increases with
      the progression of atherosclerotic disease. Heavily calcified lesions form a particular
      threat to DES; both damage to the polymer coating during vigorous advancement and inadequate
      diffusion of the drug to the subintima through extensive calcium arcs could contribute to the
      ineffectiveness of DES when implanted into such lesions, or may lead to primary stent
      delivery or expansion failure. Rotational atherectomy can effectively ablate calcified
      plaques. In the DES era, data concerning rotational atherectomy are scarce. DES implantation
      following rotablation seems a rational combination, but is only poorly supported by
      controlled studies. In the present study, we are using the polymer-based slow-release
      paclitaxel-eluting stent (TAXUS; Boston Scientific), with or without prior rotablation, in an
      angiographically well defined group of patients with complex calcified coronary lesions. This
      prospective, randomized, controlled study aims at evaluating the long term effects of both
      strategies in this complex cohort of patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In-stent late lumen loss</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events (MACE)</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-segment late lumen loss</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-segment binary restenosis</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary angiographic success</measure>
    <time_frame>Immediate</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural duration and contrast dye amount</measure>
    <time_frame>Immediate</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strategy success</measure>
    <time_frame>Immediate</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Complex Calcified Coronary Lesions</condition>
  <arm_group>
    <arm_group_label>Rotational Atherectomy + PES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Elective lesion preparation with rotational atherectomy priot to stent implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Treatment (PES without Rotational Atherectomy)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stenting without prior rotational atherectomy, usually preceeded with balloon dilatation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rotational Atherectomy + PES</intervention_name>
    <arm_group_label>Rotational Atherectomy + PES</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Treatment (PES without Rotational Atherectomy)</intervention_name>
    <arm_group_label>Standard Treatment (PES without Rotational Atherectomy)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Angiographically proven coronary artery disease

          -  Angina II-IV° following the Canadian Cardiovascular Society Classification criteria
             and/or reproducible ischemia in the target area by ECG or scintigraphy

          -  The patient signing an informed written consent

        From the following angiographic criteria, lesions must fulfil all first degree criteria and
        at least one second-degree criterion to be eligible for inclusion.

        First degree criteria

          -  De-novo lesion in a native coronary artery

          -  Target reference vessel diameter between 2.5 and 4.0 mm by visual estimation

          -  Luminal diameter reduction of 70-99% by visual estimation

          -  Moderate to severe calcification of the target lesion (clearly defined)

        Second degree criteria

          -  Ostial location

          -  Bifurcational lesions

          -  Long lesions (≥ 15mm)

        Exclusion Criteria:

          -  Myocardial infarction within 4 weeks

          -  Left ventricular ejection fraction &lt; 30%

          -  Limited long term prognosis due to other conditions

        Angiographic exclusion criteria:

          -  Unprotected left main lesions

          -  Coronary artery bypass graft stenoses

          -  In-stent restenoses

          -  Chronic total occlusions

          -  Target vessel thrombus

          -  Target vessel dissection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gert Richardt, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed A. Khattab, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Abdel-Wahab, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH</name>
      <address>
        <city>Bad Segeberg</city>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004 Jan 15;350(3):221-31.</citation>
    <PMID>14724301</PMID>
  </reference>
  <reference>
    <citation>Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004 Apr 27;109(16):1942-7. Epub 2004 Apr 12.</citation>
    <PMID>15078803</PMID>
  </reference>
  <reference>
    <citation>Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002 Jun 6;346(23):1773-80.</citation>
    <PMID>12050336</PMID>
  </reference>
  <reference>
    <citation>Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 2;349(14):1315-23.</citation>
    <PMID>14523139</PMID>
  </reference>
  <reference>
    <citation>Schofer J, Schlüter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, Breithardt G; E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003 Oct 4;362(9390):1093-9.</citation>
    <PMID>14550694</PMID>
  </reference>
  <reference>
    <citation>Warth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M. Rotational atherectomy multicenter registry: acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol. 1994 Sep;24(3):641-8.</citation>
    <PMID>8077533</PMID>
  </reference>
  <reference>
    <citation>Moussa I, Di Mario C, Moses J, Reimers B, Di Francesco L, Martini G, Tobis J, Colombo A. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results. Circulation. 1997 Jul 1;96(1):128-36.</citation>
    <PMID>9236427</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2006</study_first_submitted>
  <study_first_submitted_qc>September 25, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2006</study_first_posted>
  <last_update_submitted>January 4, 2013</last_update_submitted>
  <last_update_submitted_qc>January 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

